- Trials with a EudraCT protocol (6,324)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
6,324 result(s) found for: 15 - 30.
Displaying page 47 of 317.
EudraCT Number: 2005-005402-22 | Sponsor Protocol Number: GT-11 | Start Date*: 2006-02-08 |
Sponsor Name:ALK-Abelló A/S | ||
Full Title: A randomised, double-blind, placebo-controlled, multi-centre Phase I Trial investigating the safety of GRAZAX-R in children aged 5-12 years with grass pollen induced rhinoconjunctivitis (with/witho... | ||
Medical condition: IgE mediated allergy (hay fever, rhinoconjunctivitis) to grass pollen (Timothy grass, Phleum pratense) with or without asthma | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-003123-37 | Sponsor Protocol Number: | Start Date*: 2006-10-12 |
Sponsor Name:University Hospital Sint Radboud | ||
Full Title: Treatment with high dose Methotrexate in patients with eosinophilic fasciitis | ||
Medical condition: Eosinophilic fasciitis (EF) is a skin disorder involving the deep fascia, resulting in pain and swelling of extremities, cutaneous induration and joint contractures. Most patients require therapy. ... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2005-001658-25 | Sponsor Protocol Number: A6391002 | Start Date*: 2005-06-16 |
Sponsor Name:Pfizer Global Research and Development | ||
Full Title: An open label, two period crossover study to explore the safety, pharmacokinetics and pharmacodynamics of PHA-794428 after single subcutaneous injections in adult male patients with growth hormone ... | ||
Medical condition: AGHD Adult Growth Hormone Deficiency | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-002523-14 | Sponsor Protocol Number: A536-03 | Start Date*: 2012-12-20 | ||||||||||||||||
Sponsor Name:Acceleron Pharma Inc. | ||||||||||||||||||
Full Title: A Phase 2, Open-Label, Ascending Dose Study of ACE-536 for the Treatment of Anemia in Patients with Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) | ||||||||||||||||||
Medical condition: Myelodysplastic Syndromes (MDS) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2005-004532-43 | Sponsor Protocol Number: E-716/D9612L00095 | Start Date*: 2006-02-07 |
Sponsor Name:Klinikum Großhadern, ENT-Department | ||
Full Title: Treatment of extraesophageal manifestations of laryngopharyngeal reflux with Nexium (esomeprazole) 20mg bid, a doubleblind placebo controlled study | ||
Medical condition: Patients with laryngopharyngeal reflux symptoms will be treated with PPI or Placebo | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2012-003409-86 | Sponsor Protocol Number: Methnalox2012 | Start Date*: 2012-10-09 |
Sponsor Name:KULeuven | ||
Full Title: The effect of naloxone and methylnaltrexone on oesophageal sensitivity in healthy volunteers: a randomized, double-blind placebo controlled study. | ||
Medical condition: Altered oesophageal sensitivity | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2019-001735-31 | Sponsor Protocol Number: VX18-445-109 | Start Date*: 2019-09-13 | |||||||||||
Sponsor Name:Vertex Pharmaceuticals Incorporated | |||||||||||||
Full Title: A Phase 3b, Randomized, Double blind, Controlled Study Evaluating the Efficacy and Safety of VX-445/Tezacaftor/Ivacaftor in Cystic Fibrosis Subjects, Homozygous for F508del | |||||||||||||
Medical condition: Cystic Fibrosis | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-003194-27 | Sponsor Protocol Number: ML3602 | Start Date*: 2006-08-02 | |||||||||||
Sponsor Name:University Hospitals KU Leuven | |||||||||||||
Full Title: mirtazapine versus placebo in functional dyspepsia: a randomized, double-blind, placebo-controlled trial | |||||||||||||
Medical condition: functional dyspepsia diagnosed according to international consensus criteria ("Rome II criteria") | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-002535-12 | Sponsor Protocol Number: kimcl2004-08 | Start Date*: 2004-11-19 |
Sponsor Name:Clinical Institute of Medical and Chemical Laboratory Diagnostics Graz | ||
Full Title: Fluvastatin 80 mg ret. vs combination with ezetimib 10 mg | ||
Medical condition: elevated LDL-C | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2007-005157-33 | Sponsor Protocol Number: 1 | Start Date*: 2008-05-14 |
Sponsor Name:Ludwig Boltzmann Institut für Retinologie und biomikroskopische Laserchirurgie | ||
Full Title: A randomized observer and subject masked trial comparing the visual outcome after treatment with ranibizumab or bevacizumab in patients with neovascular age-related macular degeneration Multicenter... | ||
Medical condition: Subjects of either gender, aged> 50 years, presenting with subfoveal choroidal neovascularization due to age-related macular degeneration | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2009-011244-19 | Sponsor Protocol Number: EC08/00154 | Start Date*: 2009-12-04 |
Sponsor Name:Fundación para la Investigación Biomédica del Hospital Universitario La Paz-Sección Cirugía Torácica | ||
Full Title: Ensayo clínico en Fase I-IIa para comprobar la factibilidad y seguridad del uso autólogo de células madre derivadas de la grasa expandidas "in vitro" para el tratamiento local de fístulas traqueo-e... | ||
Medical condition: Tratamiento local de fístulas traqueo-esofágicas. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2009-015776-95 | Sponsor Protocol Number: ENM-DA012 | Start Date*: 2010-03-24 |
Sponsor Name:Universitätsklinik für Innere Medizin, Klinische Abteilung für Endokrinologie und Nuklearmedizin | ||
Full Title: Effects of vitamin D supplementation in coronary artery disease patients with postchallenge hyperglycemia and vitamin D deficiency on endothelial function and insulin sensivitivity | ||
Medical condition: subjects with coronary artery disease, postchallenge hyperglycemia and low levels of 24-OH-vitamin D | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2010-023849-30 | Sponsor Protocol Number: CSCAbrein&cognitie1-04 | Start Date*: Information not available in EudraCT |
Sponsor Name:University of Amsterdam | ||
Full Title: The effects of MR and GR blockade on the reconsolidation and extinction of fear memories | ||
Medical condition: Fear conditioning acquisition, reconsolidation and extinction in healthy male subjects. | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-000950-23 | Sponsor Protocol Number: OSMAK-POUSSIER-HorsAOI2013 | Start Date*: 2013-05-14 | |||||||||||
Sponsor Name:CHU Dijon | |||||||||||||
Full Title: | |||||||||||||
Medical condition: | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-006193-36 | Sponsor Protocol Number: P091122 | Start Date*: 2016-02-16 | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | |||||||||||||
Full Title: | |||||||||||||
Medical condition: | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-004958-14 | Sponsor Protocol Number: E2090-S082-409 | Start Date*: 2017-04-24 |
Sponsor Name:Eisai Korea Inc. | ||
Full Title: A Korean Open-label, Multi-center, Community-based Trial Assessing the Efficacy and Safety of Zonisamide as Adjunctive Therapy in Patients With Uncontrolled Partial Epilepsy | ||
Medical condition: Epilepsy | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: (No results available) |
EudraCT Number: 2004-005018-35 | Sponsor Protocol Number: SAS-6/UCA | Start Date*: 2005-10-31 |
Sponsor Name:Dr. Falk Pharma GmbH | ||
Full Title: Randomized, single-blind, multicentre study to compare the efficacy and safety of once daily 1 g mesalazine suppositories versus three times daily 0.5 g mesalazine suppositories in patients with ac... | ||
Medical condition: acute ulcerative proctitis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2004-004990-27 | Sponsor Protocol Number: TMC114-C151 | Start Date*: 2005-05-09 |
Sponsor Name:TIBOTEC PHARMACEUTICALS LTD. | ||
Full Title: The pharmacokinetic interaction between TMC114, lopinavir and ritonavir, in HIV-1 infected subjects. | ||
Medical condition: Treatment of HIV-1 infected subjects | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IT (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-003812-23 | Sponsor Protocol Number: 107014 | Start Date*: 2006-12-21 |
Sponsor Name:NV Organon | ||
Full Title: Pregnancy and neonatal follow-up of ongoing pregnancies established after controlled ovarian stimulation in clinical trial 107012 for the development of Org 36286 (corifollitropin alfa) | ||
Medical condition: Controlled Ovarian Stimulation (COS) to induce the development of multiple follicles in patients participating in an Assisted Reproductive Technology (ART) program | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: SE (Completed) AT (Completed) CZ (Completed) FR (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-005508-14 | Sponsor Protocol Number: 12631 | Start Date*: 2007-02-21 |
Sponsor Name:Bayer Consumer Care AG | ||
Full Title: A randomized, , double-blind, single centre, intra-individual comparison study with repeated application to assess the wound-healing efficacy of a 5 % Dexpanthenol ointment compared with placebo in... | ||
Medical condition: Epidermal abrasive wounds | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
